Study of memory decline in Alzheimer’s disease
Part of Brain & nervous system, Mental health clinical trials.
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can speak and understand Cantonese well enough for thinking tests
- A doctor has diagnosed you with Alzheimer’s disease
- Your decline stage fits FAST stage 3 to 5
- You are willing to have blood drawn for the study
- You have a reliable family caregiver who can answer study questions at least monthly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital tool that may help detect early signs of memory decline in people aged 50 and older. If you join, you'll help doctors learn if this tool can find memory issues earlier in community settings.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
This Phase 3 study looks for blood/brain “biomarkers” linked to aging, memory changes, and early brain degeneration. It may help researchers better identify who is at risk and how biology relates to thinking and memory, using brain scans and thinking tests.
This study looks at past memory test scores to see if they can predict how quickly memory declines in people with Alzheimer's disease. It aims to help doctors plan better care.
This study looks at how memory and thinking skills change in older adults living in the Yuyuan community. By taking part, you'll help researchers learn more about brain health in aging, and you'll have free health check-ups like memory tests and brain scans.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.